Do you want to read an article? Please log in or register.
Sparing Functional Lung Using Optimized Volumetric Modulated Arc Therapy in Thoracic Radiation for Locally Advanced Non-Small Cell Lung Cancer
Lung, Respiratory and Thoracic Cancer
Related content
Lung, Respiratory and Thoracic CancerRadio-Oncology
Sparing Cardiac Substructures with Optimized Volumetric Modulated Arc Therapy and Intensity-Modulated Proton Therapy in Thoracic Radiation for Locally Advanced Non-Small Cell Lung Cancer
Pract Radiat Oncol.
Ferris MJ, Sykes K, Switchenko JM, Kayode OA, Wolf J, Dang Q, Press RH, Curran WJ, Higgins KA
doi: 10.1016/j.prro.2019.04.013.
Lung, Respiratory and Thoracic Cancer
Alternative Multidisciplinary Management Options for Locally Advanced Non-Small Cell Lung Cancer During the COVID-19 Global Pandemic
J Thorac Oncol.
Kumar S, Chmura S, Robinson C, Lin SH, Gadgeel SM, Donington J, Feliciano J, Stinchcombe TE, Werner-Wasik M, Edelman MJ, Moghanaki D
doi: 10.1016/j.jtho.2020.04.016.
Lung Cancer
Molecular Diagnostic and Precision Medicine in Non-Small Cell Lung Cancer. An Update on the Treatment of the Most Important Actionable Oncogenic Driver Alterations.
1Department of Medical Oncology, University Hospital Basel, Basel, Switzerland.
RECOMMENDED
Lung, Respiratory and Thoracic Cancer
Prospective trial of immuno(chemo)therapy before resection, definitive chemoradiotherapy or palliative therapy in patients with locally advanced or oligometastatic non-small cell lung cancer without a primary curative option
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Eur J Cancer
Faehling M, Fallscheer S, Kramberg S, Sträter J, Eschmann S, Sätzler R, Heinzelmann F
doi: 10.1016/j.ejca.2021.07.035
RECOMMENDED
Lung, Respiratory and Thoracic CancerRadio-Oncology
A prospective study of the feasibility of FDG-PET/CT imaging to quantify radiation-induced lung inflammation in locally advanced non-small cell lung cancer patients receiving proton or photon radiotherapy
Eur J Nucl Med Mol Imaging.
Jahangiri P, Pournazari K, Torigian DA, Werner TJ, Swisher-McClure S, Simone CB 2nd, Alavi A
doi: 10.1007/s00259-018-4154-5.
Lung, Respiratory and Thoracic Cancer
Multimodality Therapy for N2 Non-Small Cell Lung Cancer: An Evolving Paradigm
Ann Thorac Surg.
Spicer JD, Shewale JB, Nelson DB, Mitchell KG, Bott MJ, Vallières E, Wilshire CL, Vaporciyan AA, Swisher SG, Jones DR, Darling GE, Sepesi B
doi: 10.1016/
RECOMMENDED
Lung, Respiratory and Thoracic Cancer
Impact of chemoradiotherapy on the immune-related tumour microenvironment and efficacy of anti-PD-(L)1 therapy for recurrences after chemoradiotherapy in patients with unresectable locally advanced non-small cell lung cancer
★ 2
Recommended by
Alexander Meisel, Faculty Member
Eur J Cancer
Shirasawa M, Yoshida T, Matsumoto Y, Shinno Y, Okuma Y, Goto Y, Horinouchi H, Yamamoto N, Watanabe SI, Ohe Y, Motoi N
doi: 10.1016/j.ejca.2020.08.028
Bevacizumab Plus Pemetrexed Versus Pemetrexed Alone as Maintenance Therapy for Patients With Advanced Nonsquamous Non-Small-cell Lung Cancer: Update From the Swiss Group for Clinical Cancer Research (SAKK) 19/09 Trial.
Clin Lung Cancer.
Gautschi O, Rothschild SI, Li Q, Matter-Walstra K, Zippelius A, Betticher DC, Früh M, Stahel RA, Cathomas R, Rauch D, Pless M, Peters S, Froesch P, Zander T, Schneider M, Biaggi C, Mach N, Ochsenbein AF; Swiss Group for Clinical Cancer Research
doi: 10.1016/
Lung, Respiratory and Thoracic Cancer
Advanced Stage Non-Small Cell Lung Cancer: Advances in Thoracic Oncology 2018
J Thorac Oncol.
Remon J, Ahn MJ, Girard N, Johnson M, Kim DW, Lopes G, Pillai RN, Solomon B, Villacampa G, Zhou Q
doi: 10.1016/j.jtho.2019.03.022.